100%

Scanned image of the page. Keyboard directions: use + to zoom in, - to zoom out, arrow keys to pan inside the viewer.

Page Options

Download this Issue

Share

Something wrong?

Something wrong with this page? Report problem.

Rights / Permissions

This collection, digitized in collaboration with the Michigan Daily and the Board for Student Publications, contains materials that are protected by copyright law. Access to these materials is provided for non-profit educational and research purposes. If you use an item from this collection, it is your responsibility to consider the work's copyright status and obtain any required permission.

October 08, 2003 - Image 10

Resource type:
Text
Publication:
The Michigan Daily, 2003-10-08

Disclaimer: Computer generated plain text may have errors. Read more about this.



Wednesday
October 8, 2003
www.michigandaily.com
sports@michigandaily.com

PORTS

10

1)9

'S 4-2 1'ASS TIl MI

I1RA

?19

By Kyle O'Neill
Daily Sports Editor
There is hardly reason to celebrate this
Michigan football team, given its 1-2 play
in its past three games. But despite not
being able to play for a national champi-
onship and for being on the brink of elimi-
nation from the Big Ten title, there have
been some good things about these Wolver-
ines halfway through the season.

be. But even despite the lesser stats in the past
few weeks, Perry has been producing even more
than he should (see offensive line). Backup
David Underwood has settled in at the No. 2
role, but his absence from bigger games like
Oregon and Iowa is noticeable. Pierre Rembert
has seen quality time in blowout wins and on
special teams to return kicks.

players at the position. Massaquoi's second-half
emergence will be a key if Michigan can
reestablish its play-action as its dominant form
of pass, rather than just the straight drop-back
or shotgun at the end of the game.

the ball back for the offense to at least attempt a
comeback drive against Oregon and Iowa). The
only knock on this squad is its lack of game-
changing plays. Defensive end Larry Stevens has
one safety, but the Wolverines have managed just
two fumble recoveries in six games. While the
Wolverines have just 15 sacks, they have forced
opposing quarterbacks to throw the ball away
due to pressure at least five times each game - a
statistic not usually blown up enough.

4

Three people are keeping this grade from
failing: Garrett Rivas and his consistent field-
goal kicking, Adam Finley and his five punts
inside the 20 and Steve Breaston and his 17
yards per punt return. After that, though, it
gets a little rougher than a chemical engineer-
ing exam. Michigan's punt coverage is giving
up 18 yards a return, negating anything good
that Finley is doing. Three blocked punts and
a blocked extra point doesn't speak well for
those up front protecting, either.
_iA

Starter John Navarre was a "B" going into this
season, and guess what? He still is. Navarre's
numbers (248.3 yards/game and 11 touchdowns)
would suggest "A" or "A-", but unfortunately a
quarterback is judged by one thing: Wins.
Navarre is four of six in that department -hence
the continual "B" that will follow him around
until he can produce two or three more victories
like last season's Outback Bowl. Backup Matt
Gutierrez has played a very limited role, but looks
to be the heir apparent to Navarre. Gutierrez has
yet to even attempt a deep ball, leaving that the
only question of his talent thus far.

This is the most flashy, modest and under-
ranked position on the team. Explosive Braylon
Edwards has done what he was advertised to
do: Make plays (36 receptions and six touch-
downs). Jason Avant has quietly made a name
for himself with just two drops and 397 yards in
five games. Then there is soft-spoken Steve
Breaston. The redshirt freshman has taken the
Wolverine nation by storm with his punt returns
and speed out of passing routes. Yet, as last
week against Iowa showed, teams are now
focusing a lot of attention in stopping the young
phenom. Breaston's end-arounds and punt
returns were hardly a factor. The senior trio of
Calvin Bell, Tyrece Butler and Jermaine Gonza-
les have all played limited roles and will proba-
bly stay in those roles for the rest of the season.
Tight end Tim Massaquoi has not been involved
with Michigan's offense when compared to past

In all reality, this line is better than a "C+" but
in terms of expectations, Michigan's big nasties
up front have had their share of problems as of
late. The line has allowed just nine sacks, but
seven of them have come in the Wolverines' two
losses. And in those games, Michigan managed
just 71 net yards rushing. All the 300-yard-plus
rushing performances against the cupcakes this
year won't make up for that.

i ne iviarun Jackson experiment in the
safety position has been a success. Jackson,
with Ernest Shazor, has been lighting up any
opposing wide receiver that tries to come
over the middle, and both are partly respon-
sible for allowing just two touchdowns in the
air this season. Jeremy LeSueur has been a
pleasant surprise at cornerback for Michigan
fans. He and opposite corner Markus Curry
have combined for nine pass deflections and
three interceptions. Depth at the corner posi-
tion is a concern, though. No one beside
Leon Hall has seen much playing time - a
problem given LeSueur's recent injury to his
left arm. There is plenty of depth at safety,
though, as Jacob Stewart has been seeing
lots of quality game time. Underclassmen
Willis Barringer, Prescott Burgess and Ryan
Mundy have all been getting some action
this season in preparation for when their
time comes. Like the defensive front seven,
the only way this crew improves its grade is
to begin making plays for their own scores
or to set up easy offensive scores.

Yes, Chris Perry is no longer the Heisman
Trophy-winning back that fans wanted him to

Michigan has answered the call all season,
shutting teams down when it needs to (i.e. getting

Coaches should never be measured by how
they start. How they respond, reevaluate and
recover is how theirseason should be graded -
no matter what the preseason expectations were.

'M' freshmen relax with virtual Agassi Greenless begins development to

4

By Kyle Carpenter "There was a little nerves in there
Daily Sports Writer and at times the level of tennis wasn't

As the Michigan men's tennis team
huddled up after a hard day of practice
yesterday, freshmen Steve Peretz, Ryan
Heller and Brian Hung exhaustedly
chanted "team" on three and packed up
for the day. Though tired, the three new
Wolverines have proven themselves

as good as they are capable of what
they are doing," Mees said. "But, they
competed extremely hard, they came
through at some big times and played
some really good tennis."
The three athletes would like to see
their team succeed deep into the post-
season, and they all 'iope to play a

ready for battles at the col-
legiate level.
The three youngsters
bring enthusiasm and live-
liness to the team, which
proves to be a great addi-
tion to the squad.
"They're three pretty tal-
ented kids ... three com-

THIS WEEKEND
Michigan hosts
Michigan Invitational
Time: Friday - Sunday
Varsity Tennis Center

prominent role in that
process.
"As a team I think we all
want to be in the top 25,"
Hung said.
His teammate echoed the
same sentiment.
"I would like to see us
make it to the Sweet Six-

once again as they welcome competi-
tion into Ann Arbor for the Michigan
Invitational. All three will see signifi-
cant action again this weekend and
hope to gain some preseason confi-
dence before dual meets begin in the
winter season.
Mees expects his players to come out
hard and show enthusiasm in the
upcoming tournament.
"Last weekend was a lot of work, and
we definitely were a little sore after-
ward, but it should be fun," Heller said.
Peretz added that they would be see-
ing even more competition in the
Michigan Invitational than they did last
weekend.
The experience through competition
will pay off as the season progresses,
but the rookies always find a way to
sharpen their skills, on and off the
court.
Hung and Peretz, who are roommates
at West Quad Residence Hall, say they
enjoy relaxing after a day of class and
tennis by playing ... tennis video games.
"I used to play Virtua Tennis 2K2 and
then way back on (Sega) Genesis, Agas-
si Tennis where you can hit diving vol-
lies as a returning serve," Peretz said.
Hung's favorite differed because of
where he was brought up and is a fan of
"Prince of Tennis."

By Phil Koful
Daily Sports Writer
There are 23 varsity sports teams that represent the
University of Michigan. Every single team has a few
standout members, but very few of them get the recog-
nition they deserve. The Michigan men's cross country
team has two All-Americans, Nate Brannen
and Nick Willis, but you may soon be hear- -
ing of a third. Senior Tom Greenless hasF
burst into the spotlight this season, leading M
the Wolverines in two races this year and Mich
being the number two man twice.
He will quickly divert any attention from T
himself though, and place it on the team. He
keeps his personal goals private, but isn't Gran
hesitant to tell you how much he thinks of
the team, and what it can do.

I become Blue's next All-American

spring,"Warhurst said.
Warhurst feels what has really made the difference
this season is the summer that Greenless had. Not in
terms of his physical training, but how much he grew
up this summer.
"He's just matured," Warhurst said. "He's grown
into himself as a person. The most important thing
Tom has improved on is his confi-
dence. A lot of the kids have the phys-
IDAY ical ability, but when it comes down
to putting on the jersey, they don't
higan at have that mentality - Tom does."
ntercollegiate Greenless himself attributes a greater
: 3 p.m. sense of patience toward his recent
endale improvement. He knows now that he
Valley State can go out a bit slower, and that he has
the strength to make his move towards
the end.

I

R
4ic
an I
une
All
idV

petitive kids and three very tough kids,"
coach Mark Mees said.
Last weekend at the Tom Fallon Invi-
tational at Notre Dame, the rookies
were able to tuck away a few matches
under their belts in admirable fashion.
Peretz, a Brooklyn, N.Y., native,
stomped the competition and went
undefeated through four games on the
weekend and also won a doubles match
with junior Vinny Gossain. Heller, orig-
inally from Chicago, and Hung, who
made his way from Hong Kong, both
finished 2-2 in their collegiate debut.

teen hopefully, maybe win the Big Ten
and get that ring," Heller said.
Individually, all three agree that
being a part of the starting lineup
would make their freshman years a suc-
cess.
"I'd like to break the top part of the
lineup," Peretz said.
Though it is still early in the year and
all players are continually improving,
the freshmen are certainly in the mix
according to Mees.
This weekend, the youngsters and the
rest of the team will pick up the rackets

"Our expectations are real high, we're an old team,"
Greenless said. "We have a lot of experience and we
know what we need to do to get to the top. One of our
goals is to be able to have the second through seventh
guy running behind Nate and Nick."
Greenless came on strong last season, finishing third
for Michigan at both the Big Ten championship and at
the NCAA championship meet. Coach Ron Warhurst,
decided to red-shirt Greenless during indoor track so he
could concentrate solely on training and get a break
from competing. It helped.
"When it came time to go, he was ready to go last

This added maturity has helped Greenless to keep his
focus this season. Last week, he went through the hard-
est week of practice yet, and then took three finals on
Thursday. The next day, Greenless put the week behind
him and finished an impressive fourth at the Notre
Dame Invitational.
Greenless, along with the other top six runners, will
be taking a well deserved break this Friday. Nine other
runners will be traveling to Grand Valley State Univer-
sity in Allendale to compete in the Michigan Intercolle-
giate. The top five will travel to Cedar Falls, Iowa, for
the pre-national meet.

0

Depo-Proverag'

Contraceptive Injection

3irtk con-~trol yiou tkir-k agoutt just L+1-Y, a year

P A RT ME NT HOM E S
A for enabe!
1,2&3Bedroom Apartment Homes

medroxyprogesterone acetate injectable suspension

DEPO-PROVERAs Contraceptive Injection
(medroxyprogesterone acetate injectable suspension, USP)
This product is intended to prevent pregnancy. It does not protect against HIV
infection (AIDS) and other sexually transmitted diseases.
What is DEPO-PROVERA Contraceptive Injection?
DEPO-PROVERA Contraceptive injection is a form of birth control that is given as an
intramuscular injection (a shot) in the buttock or upper arm once every 3 months (I weeks). To
continue your contraceptive protection, you must return for your next injection promptly at the
end of 3 months (13 weeks). DEPO-PROVERA contairfs medroxyprogesterone acetate, a
chemical similar to (but not the same as) the natural hormone progesterone, which is produced
by your ovaries during the second half of your menstrual cycle. DEPO-PROVERA acts by
preventing your egg cells from ripening. If an egg is not released from the ovaries during your
menstrual cycle, it cannot become fertilized by sperm and result in pgnancy. DEPO-PROVERA
also causes changes in the lining of your uterus that make it less likely or pregnancy to occur.
How effective is DEPO-PROVERA Contraceptive Injection?
The efficacy of DEPO-PROVERA Contraceptive Injection depends on following the
recommended dosage schedule exactly (see "How often do I get my shot of DEPO-PROVERA
Contraceptive Injection?"). To make sure you are not pregnant when you first get
DEPO-PROVERA Contraceptive Injection, your first injection must be given ONLY during
the first 5 days of a normal menstrual period; ONLY within the first 5 days after childbirth if not
breast-feeding; and. if exclusively breast-feeding, ONLY at the sixth week after childbirth. It is a
long-term injectable contraceptive when administered at 3-month (13-week) intervals.
DEPO-PROVER Contraceptive Injection is over 99% effective, making it one of the most reiable
methods of birth control available. This means that the average annual pregnancy rate is less than
one for every 100 women who use DEPO-PROVERA. The effectiveness of most contraceptive
methods depends in part on how reliably each woman uses the method. The effectiveness of
DEPO PROVERA depends only on the patient returning every 3 months (13 weeks) for her next
injection. Your heath-care provider will help you compare DEPO-PROVERA with other
contraceptive methods and give you the information you need in order to decide which
contraceptive method is the right choice for you.
The foliowing table shows the percent of women who got pregnant while using different kinds of
contraceptive methods. It gives both the lowest expected rate of pregnancy the rate expected
in women who use each method exactly as it should be used) and the typical rate of pregnancy
(which includes women who became pregnant because they forgot to use their birth control or
because they did not follow the directions exactly).
Percent of Women Experiencing an Accidental Pregnancy
in the First Year of Continuous Use

if you have had cancer of the breast
"if you have had a stroke
- if you have or have had blood clots (phlebitis) in your legs
"if you have problems with your liver or liver disease
if you are allergic to DEPO-PROVERA (medroxyprogesterone acetate or any of its other
ingredients).
What other things should I consider before using DEPO-PROVERA
Contraceptive Injection?
You will have a physical examination before your doctor prescribes DEPO-PROVERA. It is
important to tell your health-care provider if you have any of the following:
- a family history of breast cancer
* an abnormal mammogram (breast x-ray), fibrocystic breast disease, breast nodules or lumps, or
bleeding from your nipples
" kidney disease
" irregular or scanty menstrual periods
" high blood pressure
migraine headaches
"*asthma
Sepilepsy (convulsions or seizures)
" diabetes or a family history of diabetes
* a history of depression
- if you are takingan prescription or over-the-counter medications
This product is intended to prevent pregnancy. It does not protect against
transmission of HIV (AIDS) and other sexually transmitted diseases such as
chiamydia, genital herpes, genital warts, gonorrhea, hepatitis B, and syphilis.
What if I want to become pregnant after using DEPO-PROVERA Contraceptive
Injection?
Because DEPO-PROVERA is a long-acting birth control method, it takes some time after your last
injection for its effect to wear off Based on the results from a large study done in the United States,
for women who stop using DEPO-PROVERA in order to become pregnant, it is expected that
about half of those who become pregnant will do so in about 10 months after their last injection;
about two thirds of those who become pregnant will do so in about 12 months; about 83% of
those who become pregnant will do so in about 15 months; and about 93% of those who become
pregnant will do so in about I8 months after their last injection. The length of time you use
DEPO-PROVERA has no effect on how Iong it takes you to become pregnant after you stop using it
What are the risks of using DEPO-PROVERA Contraceptive Injection?
I Irregulor Menstruol Bleeding
The side effect reported most frequently by women who use DEPO-PROVERA for
contraception is a change in their normal menstrual cycle. During the first year of using
IDEPO-PROVERA, you might have one or more of the following changes: rregular or
unpredictable bleeding or spotting, an increase or decrease in menstrual bleeding, or no bleeding
at all. Unusually heavy or continuous bleeding, however is not a usual effect of DEPO-PROVERA:
and if this happens, you should see your health-care provider right away. With continued use of
DEPO-PROVERA, bleeding usually decreases, and many women stop having periods completely.
In clinical studies of DEPO-PROVERA55% of the women studied reported no menstrual
bleeding (amenorrhea) after I year of use, and 68% of the women studied reported no menstrual
bleeding after 2 years of use. The reason that your periods stop is because DEPO-PROVERA
causes a resting state in your ovaries. When your ovaries do not release an egg monthly the

6.0tyier Risks
Women who use hormone-based contraceptives may have an increased risk of blood clots or
stroke. Also, if a contraceptive method fails, there is a possibility that the fertilized egg will begin
to develop outside of the uterus (ectopic pregnancy). While these events are rare, you should
tell your health-care provider if you have any of the problems listed in the next section,
What symptoms may signal problems while using DEPO-PROVERA
Contraceptive Injection?
Call your health-care provider immediately if any of these problems occur following an injection
of DEPO-PROVERA:
" sharp chest pain, coughing up of blood, or sudden shortness of breath (indicating a possible clot
in the lung)
- sudden severe headache or vomiting, dizziness or fainting, problems with your eyesight or
speech, weakness, or numbness in an arm or leg (indicating a possible stroke),
" severe pain or swelling in the calf (indicating a possible clot in the leg)
- unusually heavy vaginal bleeding
- severe pain or tenderness in the lower abdominal area
persistent pain, pus, or bleeding at the injection site
What are the possible side effects of DEPO-PROVERA Contraceptive Injection?
L.Weighr Gin
You may experience a weight gain while you are using DEPO-PROVERA. About two thirds of
the women who used DEPO-PROVERA in clinical trials reported a weight gain of about 5 pounds
during the first year of use. You may continue to gain weight after the first year; Women in one
large study who used DEPO-PROVERA for 2 years gained an average total of 8.1 pounds over
those 2 years, or approximately 4 pounds per year Women who continued for 4 years gained an
average total of 13.8 pounds over those 4 years, or approximately 3.5 pounds per year Women
who continued for 6 years gained an average total of 16.5 pounds over those 6 years, or
approximately 2.75 pounds per year
2.Other Side Effects
In a clinical study of over 3,900 women who used DEPO-PROVERA for up to 7 years, some
women reported the following effects that may or may not have been related to their use of
DEPO-PROVERA: Irregular menstrual bleeding. amenorrhea, headache, nervousness, abdominal
cramps, dizziness, weakness or fatigue, decreased sexual desire, leg cramps, nausea, vaginal
discharge or irritation, breast swelling and tenderness, bloating, swelling of the hands or feet,
backache, depression, insomnia, acne, pelvic pain, no hair growth or excessive hair loss, rash, hot
flashes, and joint pain. Other problems were reported by very few of the women in the clinical
trials, but some of these could be serious. These include convulsions, jaundice, urinary tract
infections, allergic reactions, fainting, paralysis, osteoporosis, lack of return to fertility, deep vein
thrombosis, pulmonary embolus, breast cancer, or cervical cancer If these or any other problems
occur during your use of DEPO-PROVERA, discuss them with your health-care provider
Should any precautions be followed during use of DEPO-PROVERA
Contraceptive Injection?
/.Missed Periods
During the time you are using DEPO-PROVERA for contraception, you may skip a period, or your
periods may stop completely. If you have been receiving your DEPO-PROVERA injections
regularly every 3 months (13 weeks), then you are probably not pregnant. However if you think
that you may be pregnant, see your health-care provider
2.Laboratory Test Interactions
If you are scheduled for any laboratory tests, tell your health-care provider that you are using
DEPO-PROVERA for contraception. Certain blood tests are affected by hormones such as
DE'.PO- OA.

"
"
"
"

Resident Activity Center
Washer & Dryer
Carwash Center
Nature Trail

al

1100 Rabbit Run Circle
Ann Arbor, Ml 48103
Phone (734) 998-1000
Fax (734) 998-0000
www.ced-concord.com
Resort to the Lifestyle Yau Deserve.

Would you like to start a
fraternity? We have got a
great opportunity for you!
---------- ----
Local/national scholarship programs
Immediate leadership positions
145 years on campus
500+ alumni
No hazing

a

Lowest
Method Expected ypical
DEPO-PROVERA 03 03
Implants (Norpant) 0.2* 0.2'
Female s rSzi5on 02 0.4
Male sterilization 0.1 0.15

i

i

Back to Top

© 2017 Regents of the University of Michigan